Assessment time halved: Importance of a good tumor response assessment tool in clinical site reads

The Clinical Research Imaging Core (CRIC) of the University of Wisconsin Carbone Cancer Center (UWCCC) recently published a poster at the AACI CRI conference titled “Shared Investment to Build a Strong, Streamlined, and Accessible RECIST Foundation in Clinical Research”. On this poster, core manager Mr. Alex Arbuckle and faculty lead Dr. Steve Cho discuss that the previous tumor response assessment service they were using was “inflexible, cumbersome, did not align with research aspirations, and was cost prohibitive.”.

Through a joint review of various solutions, they arrived at the decision to implement mint Lesion as their centralized tumor response assessment system. The joint investment and implementation of mint Lesion by the UWCCC and UW Department of Radiology Medical Imaging Research Support has greatly improved the inclusion of imaging expertise in the assessments. Since then, it has “improved cost effectiveness, continually improved assessment time to completion, and has allowed for quick start-up and navigation of investigator initiated trials.” In the first 9 months, they were able to expand from 5 users in 2 programs to 12 users in 6 programs and halved the time required for completing an assessment.

Read the full poster by clicking here: Link to AACI CRI poster

Related Resources

Related Resources

Customizing structured data collection with mint Lesion™ Template Editor

We are thrilled to announce a forthcoming addition to mint Lesion™: the Template Editor. This feature will transform the way users interact with our…

Improving Cancer Care Through Standardization: Interview with Prof. Thomas Kröncke on the BZKF Project BORN

The Bavaria-wide oncological radiology network (BORN) Project was launched on August 1, 2022, with the objective of improving cancer care in Bavaria…

Optimizing Clinical Trials without Compromising Patient Care: An Investigational Site’s Perspective

Attracting and retaining industry-sponsored clinical trials can be quite appealing for healthcare institutions. Besides obvious financial and…